Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Val-Cit-PAB-OH is a peptide linker molecule used in the synthesis of drug conjugates.1,2,3,4 It is cleaved by cathepsin B, a protease highly expressed in cancer cells, which confers specificity of the drug conjugates to cancer cells.1 Val-Cit-PAB-OH has been used in the synthesis of antibody-drug conjugates (ADCs) containing the tubulin polymerization inhibitors KGP05 or monomethyl auristatin D (MMAD), as well as α-galactosylceramide or folic acid conjugates that target peptide antigens to natural killer T cells or exportin 1 (CRM1) inhibitors to cancer cells, respectively.2,3,4
WARNING This product is not for human or veterinary use.
1. Cathepsin B-
2. Effect of attachment site on stability of cleavable antibody drug conjugates. Bioconjug. Chem. 26(4), 650-659 (2015).
3. Augmenting influenza-
4. The nuclear export inhibitor aminoratjadone is a potent effector in extracellular-